Symrise, BRAIN and AnalytiCon: A successful par...
Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------
Symrise obtains exclusive marketing rights to new cosmetic active
ingredients thanks to its strategic partnership with biotech
specialists - product launch planned for 2009
Holzminden/Zwingenberg/Potsdam, November 20, 2008 - Symrise, one of
the world's leading manufacturers of fragrances and flavorings as
well as ingredients for cosmetics, has acquired licenses for two new
groups of cosmetic active ingredients. These promising results were
achieved in a joint development project with biotech specialist BRAIN
and natural-product company AnalytiCon. The license gives Symrise
international marketing rights.
The goal of the strategic partnership which was initiated in April
2007 was to jointly develop innovative and all-natural active
ingredients for use in cosmetics. "This alliance allows Symrise to
follow new paths in developing highly effective cosmetic ingredients
and continuing to expand its competence in the field of active
ingredients for skin and hair care," explains Gabriele Vielhaber,
Vice President, Innovation R&D, Life Essentials.
By June 30, 2008, the three cooperation partners successfully
completed two screening procedures to identify multiple groups of
innovative active ingredients thus enabling Symrise to develop new
active components for use in cosmetics.
As of October 1, 2008, Symrise has acquired the exclusive marketing
rights to two of these groups of active ingredients. Clinical tests
have proven the high efficacy of both groups, and Symrise will now
develop them with the goal of a market launch in 2009. They will be
used primarily in deodorants as well as products for sensitive skin.
"Working with companies such as BRAIN and AnalytiCon, both leaders in
their fields, has complemented our own R&D activities and made a
major contribution to our innovation pipeline after a remarkably
short development phase," as Achim Daub, head of Symrise's Scent &
Care division, says. "We will keep following this successful strategy
and are happy to have established such a powerful alliance in the
field of natural ingredients with these two outstanding partners."
Holger Zinke, CEO of BRAIN, adds, "In only 18 months we managed to
develop two `first-in-class' products, all the way from assay
development and high-throughput screening to in vivo efficacy tests.
This demonstrates the remarkable quality and strength of our joint
efforts."
"The trilateral cooperation between Symrise, BRAIN and AnalytiCon is
an outstanding example of a successful and efficient division of
labor and networking among specialized partners. The results far
exceed our expectations," as Lutz Müller-Kuhrt, head of AnalytiCon,
comments. "The intense cooperation of three such complementary
partners made us exceptionally efficient in identifying, optimizing
and developing innovative active ingredients for top-quality
cosmetics."
About Symrise
Symrise is a global supplier of fragrances, flavorings and raw
materials and active ingredients for the perfume, cosmetics and food
industry.
Its sales of ¤1.27 billion in 2007 place the company among the top
four in the international flavors and fragrances market.
Headquartered in Holzminden, Germany, Symrise is represented in more
than 30 countries in Europe, Asia, the United States and South
America.
With more than 40 first patent applications per year, Symrise is one
of the most innovative manufacturers on the market. Used by
manufacturers of perfumes, cosmetics and foods, our products are an
inseparable part of daily life. At Symrise we combine an awareness of
consumer trends with cutting-edge technologies, focusing on
innovative fashion and lifestyle products that have additional
practical value for the consumer. Symrise - always inspiring more...
www.symrise.com
Contact:
Katja Derow, red roses communications GmbH, Phone: +49-40-46 96
770-10,
Email: k.derow@redroses-pr.com
About BRAIN AG
BRAIN AG is an industrial "white" biotech company which discovers and
develops novel bioactive natural compounds and proprietary enzymes
for its partners and customers in the chemical and pharmaceutical
industries, as well as the food and cosmetics industries. With its
unique approach to the discovery and production of new biological
compounds and biocatalysts, the company achieves creative solutions
by harnessing nature's untapped biodiversity. Its success is built on
its proprietary BioArchive, comprising millions of genes, proteins
and metabolic pathways from microbial isolates and metagenome
libraries. Since its foundation in 1993, BRAIN has entered into over
50 strategic collaborations with nearly all the relevant companies
within the chemical industry. Currently, BRAIN employs 72 highly
skilled people. BRAIN has entered into partnerships with BASF, Ciba,
Clariant, Evonik Degussa, Genencor, Henkel, Nutrinova, Sandoz,
Schering, Südzucker and Symrise, to name but a few. For his
groundbreaking industrial biotechnology activities for a sustainable
"biologisation of the chemical industry" using nature`s toolbox for
industrial processes, BRAIN CEO Dr. Holger Zinke received the
"Deutschen Umweltpreis 2008" of the "Deutsche Bundesstiftung Umwelt,"
(DBU).
www.brain-biotech.de
Contact:
Dr. Martin Langer, BRAIN AG, Corporate Development; Phone:
+49-6251-9331-16,
Email: ml@brain-biotech.de
Dr. Holger Zinke, BRAIN AG, CEO; Phone: +49-6251-9331-0
Email: hz@brain-biotech.de
About AnalytiCon Discovery
The internationally operating AnalytiCon Discovery GmbH is the global
market leader in the field of natural product (NP) compound libraries
featuring fully elucidated structures. With its 60 employees at
Potsdam Biotech Campus, it offers services for every phase of the
supply chain for NP-based drug discovery and development. The
company offers the full range of services for the accelerated
development of NP-based lead structures, from procurement of raw
biomaterials to fermentation, isolation and high-throughput structure
elucidation all the way to NP-focused medicinal chemistry. The
innovative technology concept employed by AnalytiCon has led to
top-class contracts with companies from the pharmaceutical, food and
cosmetics industry in Europe, USA and Japan. Furthermore, AnalytiCon
has established the BIOS concept (Biology Oriented Synthesis), a
technology for developing and producing focused combinatorial
compound libraries based on rare NP core structures that contain
bioactive structural elements (Nat-DiverseTM). In the process, the
company has gained access to currently over 15% of all known natural
products worldwide as well as to thousands of yet-unpublished
structures.
www.ac-discovery.com
Contact:
Dr. Lutz Müller-Kuhrt, AnalytiCon Discovery GmbH, Phone:
+49-331-2300-310,
Email: lmk@ac-discovery.com
--- End of Message ---
Symrise AG
Mühlenfeldstraße 1 Holzminden Germany
WKN: SYM999; ISIN:
DE000SYM9999; Index: MDAX, TecDAX;
Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Freiverkehr
in Bayerische Börse München,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Börse Berlin,
Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart,
Prime Standard in Frankfurter Wertpapierbörse;
Latest directors dealings
- 1 hour ago Oxford Nanopore Technologies
- 2 hours ago AVI Global Trust
- 2 hours ago LSL Property Services
- 2 hours ago Bluebird Merchant Ventures (DI)
- 2 hours ago Power Probe PLC